Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04730544
Title Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI mCRC. (NIPISAFE)
Acronym NIPISAFE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors GERCOR - Multidisciplinary Oncology Cooperative Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Institut Sainte Catherine RECRUITING Avignon France Details
CHU Jean Minjoz RECRUITING Besançon France Details
CHU Morvan RECRUITING Brest France Details
Hôpital Henri Mondor RECRUITING Créteil France Details
Centre Georges François Leclerc RECRUITING Dijon France Details
Clinique Victor Hugo-Centre jean Bernard NOT_YET_RECRUITING Le Mans France Details
Hopital Franco-Britannique - Fondation Cognacq-Jay RECRUITING Levallois-Perret France Details
CHRU Lille NOT_YET_RECRUITING Lille France Details
Centre Léon Bérard NOT_YET_RECRUITING Lyon France Details
Hôpital Privé Jean Mermoz RECRUITING Lyon France Details
Hôpital de la Timone RECRUITING Marseille France Details
ICM Val d'Aurelle RECRUITING Montpellier France Details
CHU Nantes- Hôtel Dieu RECRUITING Nantes France Details
Hôpital Saint Antoine RECRUITING Paris France Details
Institut Mutualiste Montsouris RECRUITING Paris France Details
CHU Bordeaux - Hôpital Haut Lévêque RECRUITING Pessac France Details
CHU Poitiers NOT_YET_RECRUITING Poitiers France Details
Hôpital Robert Debré RECRUITING Reims France Details
CHU Toulouse - IUCT Rangueil -Larrey RECRUITING Toulouse France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field